Get started
Author

Nebojsa M. Antonijevic

Observed names: ANTONIJEVIĆ NEBOJŠA, Antonijević Nebojša, Antonijević, Nebojša, N Antonijevic, N Antonijević, N. Antonijevic, N. Antonijević, N. M. Antonijevic, Nebojsa Antonijevic, Nebojsa M Antonijevic, Nebojsa M. Antonijević, Nebojša Antonijević, Nebojša M. Antonijević
Observed institutions: University of Kragujevac, University of Belgrade, Institut za kardiovaskularne bolesti Dedinje, Univerzitetski Klinički Centar Srbije, Institute of Molecular Genetics and Genetic Engineering, Blood Transfusion Institute of Serbia, Belgrade
ORCID: 0000-0001-5395-7859
Observed ORCID: 0000-0001-5395-7859
OpenAlex ID: A5108564111
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
2017 · Marco Valgimigli, Héctor Bueno, et al. · European Heart Journal · 2,987
PDF
Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions
2017 · Nebojsa M. Antonijevic, Ivana D. Zivkovic, et al. · Current Drug Metabolism · 48
Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention
2011 · Igor Mrdovic, Lidija Savic, et al. · Coronary Artery Disease · 46
[Anemia in hypothyroidism].
1999 · N Antonijević, M Nesović, et al. · PubMed · 43
Thrombophilia in Women with Pregnancy-Associated Complications: Fetal Loss and Pregnancy-Related Venous Thromboembolism
2010 · M. Kovac, G. Mitic, et al. · Gynecologic and Obstetric Investigation · 34
Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention
2013 · Dragan M Matic, Dejan G Milasinovic, et al. · Heart · 31
Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin
2006 · Nebojsa M. Antonijevic, Nebojsa B. Savic, et al. · Journal of Clinical Apheresis · 27
Type and Location of Venous Thromboembolism in Carriers of Factor V Leiden or Prothrombin G20210A Mutation Versus Patients With No Mutation
2008 · Mirjana Kovac, Gorana Mitic, et al. · Clinical and Applied Thrombosis/Hemostasis · 21
PDF
Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention
2014 · Dragan Matic, Milika Asanin, et al. · Vojnosanitetski pregled · 20
PDF
Practical Aspects of Monitoring of Antiplatelet Therapy
2016 · Nebojsa Antonijevic, Tina Novakovic, et al. · Seminars in Thrombosis and Hemostasis · 19
Economic Analysis of Pharmacogenomic-Guided Clopidogrel Treatment in Serbian Patients with Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
2016 · Christina Mitropoulou, Vasilios Fragoulakis, et al. · Pharmacogenomics · 19
Pcr Amplification on Whole Blood Samples Treated With Different Commonly Used Anticoagulants
2006 · V. Djordjevic, M. Stankovic, et al. · Pediatric Hematology and Oncology · 19
Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention
2009 · Slobodan D Obradovic, Jovan P Antovic, et al. · Blood Coagulation & Fibrinolysis · 18
Prothrombotic Genetic Risk Factors in Stroke
2012 · Valentina Djordjevic, Marija Stankovic, et al. · Clinical and Applied Thrombosis/Hemostasis · 15
Carvedilol Increases Copper‐Zinc Superoxide Dismutase Activity in Patients with Acute Myocardial Infarction
2007 · Dragana A. Kastratović, Zorana M. Vasiljević, et al. · Basic & Clinical Pharmacology & Toxicology · 14
The Influence of Hyperthyroidism on the Coagulation and on the Risk of Thrombosis
2024 · Nebojsa Antonijevic, Dragan Matic, et al. · Journal of Clinical Medicine · 13
PDF
Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel
2017 · Mirjana Novkovic, Dragan Matic, et al. · European Journal of Clinical Pharmacology · 13
FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population
2007 · Mirjana Kovac, Danijela Mikovic, et al. · Journal of Thrombosis and Thrombolysis · 13
Efficacy and safety of nadroparin and unfractionated heparin for the treatment of venous thromboembolism during pregnancy and puerperium
2010 · Gorana Mitic, Mirjana Kovac, et al. · Srpski arhiv za celokupno lekarstvo · 12
PDF
Lethal Outcome After Intravenous Administration of Amiodarone in Patient with Atrial Fibrillation and Ventricular Preexcitation
2011 · MUJOVIĆ NEBOJŠA, SIMIĆ DRAGAN, et al. · Journal of Cardiovascular Electrophysiology · 11
+1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss
2010 · Iva Pruner, Valentina Djordjevic, et al. · Blood Coagulation & Fibrinolysis · 10
The role of rotational thromboelastometry in real time assessment of haemostasis in surgical settings
2010 · Dragica Vucelic, Predrag Miljic, et al. · Srpski arhiv za celokupno lekarstvo · 10
PDF
Antiplatelet Drugs Use in Pregnancy—Review of the Current Practice and Future Implications
2024 · Nebojsa Antonijevic, Nikola Gosnjic, et al. · Journal of Personalized Medicine · 9
Combined Thrombophilic Risk Factors and Essential Thrombocythemia in Patient with Recurrent Venous Thromboembolic Episodes—Thirty-Three-Year Follow-Up
2005 · Nebojsa Antonijevic, Milica Stanojevic, et al. · Journal of Thrombosis and Thrombolysis · 9
Beta Blockers can Mask not only Hypoglycemia but also Hypotension
2022 · Goran Koracevic, Sladjana Micic, et al. · Current Pharmaceutical Design · 8
Works count: 100
Citation count: 3,623
H-index: 14
I10-index: 22
Year
Topic
Type